From Health Canada:
Association of increased mortality and risk of serious adverse events when prophylactic low-dose heparin is abruptly discontinued in patients to be started on Xigris® [drotrecogin alfa (activated)] therapy for severe sepsis. ...more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment